If you are trying to work out whether 10x Genomics at around US$20.92 is still good value or already pricing in a lot of optimism, it helps to break the story into simple numbers first. The stock has ...
10x Genomics is bolstering its commitment to scaling single cell experiments through the acquisition of Scale Biosciences. 10x has agreed to pay $30 million in cash and stock upfront, plus an ...
“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Precision medicine company CareDx and 10x Genomics have partnered to launch ImmuneScape, a multiomics program to improve the understanding of transplant organ rejection and variability in patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results